CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00872833
NCT00872833N/ACompleted

Assessment of Pain in Transfusion Dependent Patients With Thalassemia During Transfusion Cycles

Carelon Research·observational·Posted Mar 31, 2009·Updated Oct 7, 2015

In Brief

An observational study for Thalassemia. Completed, enrolled 32 participants across 9 sites in 2 countries.

Detailed Summary

Thalassemia is an inherited blood disorder that can result in mild to severe anemia. Regular blood transfusions, which refresh the healthy red blood cell supply, are one treatment for thalassemia. People with thalassemia often experience pain, but the exact source of pain remains unknown. This study will examine how pain varies during the blood transfusion cycle in people with thalassemia who are treated with regular blood transfusions.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsThalassemia
CountriesCanada, United States

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 31, 2009
Enrollment StartJul 1, 2009
Primary CompletionOct 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 17.3 years ago